- Home
- SRZN vs NUW Comparison
SRZN vs NUW Comparison
Compare SRZN & NUW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SRZN | NUW |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | United States |
| Employees | 59 | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 271.6M | 250.6M |
| IPO Year | 2020 | 2008 |
Fundamental Metrics
Financial Performance| Metric | SRZN | NUW |
|---|---|---|
| Price | $31.95 | $12.88 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $38.00 | N/A |
| AVG Volume (30 Days) | ★ 626.2K | 90.9K |
| Earning Date | 05-08-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,477,000.00 | N/A |
| Revenue This Year | $75.35 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $11.39 | $12.70 |
| 52 Week High | $37.83 | $14.70 |
Technical Indicators
Market Signals| Indicator | SRZN | NUW |
|---|---|---|
| Relative Strength Index (RSI) | 66.69 | 20.81 |
| Support Level | $24.64 | N/A |
| Resistance Level | $33.96 | $14.53 |
| Average True Range (ATR) | 2.17 | 0.19 |
| MACD | 1.55 | -0.05 |
| Stochastic Oscillator | 62.84 | 14.52 |
Price Performance
Historical ComparisonAbout SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).
About NUW Nuveen AMT-Free Municipal Value Fund
Nuveen AMT-Free Municipal Value Fund is a diversified closed-end management investment company. The Fund's primary investment objective is to provide current income exempt from regular federal income tax. The Fund's secondary investment objective is to enhance portfolio value and total return.